TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AARTIDRUGS Stock 12 Month Forecast
There Are No Analyst Ratings for IN:AARTIDRUGS In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
AARTIDRUGS Financial Forecast
AARTIDRUGS Earnings Forecast
Next quarter’s earnings estimate for AARTIDRUGS is ₹4.90 with a range of ₹4.90 to ₹4.90. The previous quarter’s EPS was ₹4.90. AARTIDRUGS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year AARTIDRUGS has Performed in-line its overall industry.
Next quarter’s earnings estimate for AARTIDRUGS is ₹4.90 with a range of ₹4.90 to ₹4.90. The previous quarter’s EPS was ₹4.90. AARTIDRUGS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year AARTIDRUGS has Performed in-line its overall industry.
AARTIDRUGS Sales Forecast
Next quarter’s sales forecast for AARTIDRUGS is ₹5.71B with a range of ₹5.71B to ₹5.71B. The previous quarter’s sales results were ₹6.53B. AARTIDRUGS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year AARTIDRUGS has Performed in-line its overall industry.
Next quarter’s sales forecast for AARTIDRUGS is ₹5.71B with a range of ₹5.71B to ₹5.71B. The previous quarter’s sales results were ₹6.53B. AARTIDRUGS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year AARTIDRUGS has Performed in-line its overall industry.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
AARTIDRUGS Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, AARTIDRUGS has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. AARTIDRUGS average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
AARTIDRUGS Stock Forecast FAQ
What is IN:AARTIDRUGS’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:AARTIDRUGS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:AARTIDRUGS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Aarti Drugs Limited a Buy, Sell or Hold?
Currently, no data Available
What is Aarti Drugs Limited’s share price target?
Currently, no data Available
What do analysts say about Aarti Drugs Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Aarti Drugs Limited?
To buy shares of IN:AARTIDRUGS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.